김병석 (인천대학교)님 | 한빛사연구자 > 한빛사

인천대학교

최종업데이트 2025.09.08.

Discovery of natural RORγt inhibitor using machine learning, virtual screening, and in vivo validation
- J. Adv. Res., Sep 05 2025, S2090-1232(25)00687-3 | https://doi.org/10.1016/j.jare.2025.09.004
- 2025-09
- 의약학
- 한빛사논문
Boosting with variant-matched adenovirus-based vaccines promotes neutralizing antibody responses against SARS-CoV-2 Omicron sublineages in mice
- Int. J. Antimicrob. Agents, Dec 30 2023, S0924-8579(23)00371-0 | https://doi.org/10.1016/j.ijantimicag.2023.107082
- 2023-12
- 생명과학
- 한빛사논문
Nanovesicle-mediated targeted delivery of immune checkpoint blockades to potentiate therapeutic efficacy and prevent side effects
- Adv. Mater., First published: 28 December 2021 | https://doi.org/10.1002/adma.202106516
- 2021-12
- 바이오·의료융합
- 한빛사논문
Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer
- J. Immunother. Cancer, First published June 2, 2021;9:e002603 | http://dx.doi.org/10.1136/jitc-2021-002603
- 2021-06
- 생명과학
- 한빛사논문
Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma
- Proc. Natl. Acad. Sci. USA, May 11, 2010 vol. 107 no. 19 8742-8747. Published online before print April 26, 2010, doi: 10.1073/pnas.0911756107
- 2010-04
- 생명과학
- 한빛사논문

연구자 ID

저자논문